Bradley J. Bell - 27 Apr 2022 Form 4 Insider Report for Chemours Co (CC)

Reporting relationship: Director
Issuer ticker: CC
Reported as of: 27 Apr 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 29 Apr 2022, 11:37:12 UTC
Source filing: View source filing
Reporting owner signature: /s/ Pauletta Brown, Attorney-in-Fact

Key filing fact

Bradley J. Bell filed Form 4 for Chemours Co (CC) on 29 Apr 2022.

Key facts

This page summarizes Bradley J. Bell's Form 4 filing for Chemours Co (CC).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 29 Apr 2022, 11:37.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CC transaction

Common Stock

Award

Transaction value: $0
Shares: +4,442
Change %: +7.9%
Price: $0.000000
Shares after: 60,605
Date: 27 Apr 2022
Ownership: Direct
Footnotes: F1

CC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 20,400
Date: 27 Apr 2022
Ownership: By Trust

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CC holding Derivative

Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 9,422
Date: 27 Apr 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 9,422
Exercise price
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Includes directly owned shares, stock units and dividend equivalent units.

Footnote F2

Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock.

Footnote F3

Payable upon separation from service.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .